FRPH · Frp Holdings, Inc.
One customer — 26.9% of revenue (the three months ended March 31, 2026)
“one lessee that accounted for 26.9% of the Company’s consolidated revenues during the three months ended March 31, 2026, and $715,000 of accounts receivable at March 31, 2026.”
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-18 | BAKER JOHN D II |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $21.88 to $22.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range. Shares are held by the Trust FBO John D. Baker II U/A Cynthia L. Baker Trust dated 4/30/1965, for which the Reporting Person serves as co-trustee, and of which the Reporting Person is the sole income beneficiary. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
8,189 |
| 2026-08-17 | BAKER JOHN D II |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $21.85 to $22.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range. Shares are held by the Trust FBO John D. Baker II U/A Cynthia L. Baker Trust dated 4/30/1965, for which the Reporting Person serves as co-trustee, and of which the Reporting Person is the sole income beneficiary. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
957 |
| 2026-08-07 | Baker John D. III |
Director, CEO |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $21.50 to $22.00. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range. |
Common Stock
(I)
|
6,800 |
| 2026-05-14 | Wetherbee Margaret B. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
4,671 |
| 2026-05-14 | WALTON WILLIAM H III |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
4,671 |
| 2026-05-14 | Thomas Nicole B. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
4,671 |
| 2026-05-14 | McAfee Matthew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
4,671 |
| 2026-05-14 | Surface John S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
4,671 |
| 2026-05-14 | STEIN MARTIN E JR |
Director, Executive Chairman |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
4,671 |
| 2026-03-23 | BAKER JOHN D II |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shares are held by the Trust FBO John D. Baker II U/A Cynthia L. Baker Trust dated 4/30/1965, for which the Reporting Person serves as co-trustee, and of which the Reporting Person is the sole income beneficiary. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
478,468 |
| 2026-03-10 | deVilliers David H III |
President & COO |
Other↓
Filing footnotes — Common Stock (Direct)
Represents the forfeiture of restricted stock originally granted to the Reporting Person on January 1, 2024 due to the Issuer not achieving the target performance criteria. |
Common Stock
|
548 |
| 2026-03-10 | Klopfenstein John D |
Controller & CAO |
Other↓
Filing footnotes — Common Stock (Direct)
Represents the forfeiture of restricted stock originally granted to the Reporting Person on January 1, 2024 due to the Issuer not achieving the target performance criteria. |
Common Stock
|
276 |
| 2026-03-10 | McNulty Matthew C. |
CFO |
Other↓
Filing footnotes — Common Stock (Direct)
Represents the forfeiture of restricted stock originally granted to the Reporting Person on January 1, 2024 due to the Issuer not achieving the target performance criteria. |
Common Stock
|
418 |
| 2026-03-10 | DEVILLIERS DAVID H JR |
Director, Sr. Advisor to Pres. & COO |
Other↓
Filing footnotes — Common Stock (Direct)
Represents the forfeiture of restricted stock originally granted to the Reporting Person on January 1, 2024 due to the Issuer not achieving the target performance criteria. |
Common Stock
|
548 |
| 2026-03-10 | Baker John D. III |
Director, CEO |
Other↓
Filing footnotes — Option to Buy (Direct)
Represents the forfeiture of options originally granted to the Reporting Person on January 1, 2024 due to the Issuer not achieving the target performance criteria. |
Option to Buy
|
2,733 |
| 2026-02-19 | BAKER JOHN D II |
Director |
Gift↓
Filing footnotes — Common Stock (Indirect)
The reported disposition reflects a distribution of shares in connection with the termination of the Reporting Person's grantor retained annuity trust. The shares were distributed to irrevocable trusts for the benefit of the Reporting Person's children. |
Common Stock
(I)
|
48,721 |
| 2026-02-12 | Baker John D. III |
Director, CEO |
Gift↑
Filing footnotes — Common Stock (Indirect)
In connection with the termination of John D. Baker II's grantor retained annuity trust, 48,721 shares were distributed to the John D Baker II 2018 Irrevocable Trust FBO John D Baker III. The Reporting Person serves as co-trustee and is the sole beneficiary of such trust. |
Common Stock
(I)
|
48,721 |
| 2026-02-12 | BAKER JOHN D II |
Director |
Gift↑
Filing footnotes — Common Stock (Indirect)
The reported disposition reflects a distribution of shares in connection with the termination of the Reporting Person's grantor retained annuity trust. The shares were distributed to irrevocable trusts for the benefit of the Reporting Person's children. This item was amended to reflect the correct amount of securities beneficially owned following the reported disposition. |
Common Stock
(I)
|
97,442 |
| 2026-01-30 | BAKER JOHN D II |
Director |
Gift↓
Filing footnotes — Common Stock (Indirect)
The Reporting Person gifted shares to family members. |
Common Stock
(I)
|
54,824 |
| 2026-01-27 | BAKER JOHN D II |
Director |
Gift↓
Filing footnotes — Common Stock (Indirect)
The Reporting Person gifted shares to family members. |
Common Stock
(I)
|
109,648 |
| 2026-01-27 | Baker John D. III |
Director, CEO |
Gift↑
Filing footnotes — Common Stock (Indirect)
The Reporting Person was gifted shares by a family member. |
Common Stock
(I)
|
54,824 |
| 2026-01-02 | Baker John D. III |
Director, CEO |
Gift↓
Filing footnotes — Common Stock (Indirect)
The Reporting Person gifted shares to family members. |
Common Stock
(I)
|
1,673 |
| 2026-01-01 | DEVILLIERS DAVID H JR |
Director, Sr. Advisor to Pres. & COO |
Award↑
Filing footnotes — Common Stock (Direct)
This amendment revises the footnote included on the original filing to reflect that the Reporting Person was awarded restricted shares pursuant to the Issuer's Equity Incentive Plan. The shares vest ratably over four years commencing on December 31, 2026. |
Common Stock
|
2,632 |
| 2026-01-01 | deVilliers David H III |
President & COO |
Award↑
Filing footnotes — Common Stock (Direct)
This amendment revises the footnote included on the original filing to reflect that the Reporting Person was awarded restricted shares pursuant to the Issuer's Equity Incentive Plan. The shares vest ratably over four years commencing on December 31, 2026. |
Common Stock
|
6,580 |
| 2026-01-01 | McNulty Matthew C. |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
This amendment revises the footnote included on the original filing to reflect that the Reporting Person was awarded restricted shares pursuant to the Issuer's Equity Incentive Plan. The shares vest ratably over four years commencing on December 31, 2026. |
Common Stock
|
5,264 |
| 2026-01-01 | Baker John D. III |
Director, CEO |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person was awarded shares of restricted stock pursuant to the Issuer's Equity Incentive Plan. The shares are subject to performance-based vesting criteria for the two-year period ending December 31, 2027. If the performance-based criteria are achieved, 25% of the shares will vest upon the Compensation Committee's determination (in March 2028) that such criteria have been achieved, and 25% will vest on December 31st of each of 2028, 2029, and 2030, subject to the Reporting Person's continued employment. |
Common Stock
|
9,216 |
| 2026-01-01 | Baker John D. III |
Director, CEO |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person was awarded options pursuant to the Issuer's Equity Incentive Plan. The options vest ratably over four years commencing on December 31, 2026. |
Common Stock
|
6,580 |
| 2026-01-01 | Baker John D. III |
Director, CEO |
Award↑
Filing footnotes — Common Stock (Direct)
This amendment revises the footnote included on the original filing to reflect that the Reporting Person was awarded restricted shares pursuant to the Issuer's Equity Incentive Plan. The shares vest ratably over four years commencing on December 31, 2026. |
Common Stock
|
6,580 |
| 2026-01-01 | Klopfenstein John D |
Controller & CAO |
Award↑
Filing footnotes — Common Stock (Direct)
This amendment revises the footnote included on the original filing to reflect that the Reporting Person was awarded restricted shares pursuant to the Issuer's Equity Incentive Plan. The shares vest ratably over four years commencing on December 31, 2026. |
Common Stock
|
2,192 |
| 2025-12-29 | Baker John D. III |
Director, CEO |
Gift↓
Filing footnotes — Common Stock (Indirect)
The Reporting Person gifted shares to family members. |
Common Stock
(I)
|
5,887 |
| 2025-12-11 | deVilliers David H III |
President & COO |
Sell↓
|
Common Stock
|
1,500 |
| 2025-12-01 | DEVILLIERS DAVID H JR |
Director, Sr. Advisor to Pres. & COO |
Convert↓
|
Option to Buy
|
14,080 |
| 2025-12-01 | DEVILLIERS DAVID H JR |
Director, Sr. Advisor to Pres. & COO |
Convert↑
Filing footnotes — Common Stock (Direct)
The Reporting Person acquired shares through a cashless exercise transaction with the issuer in which the Reporting Person surrendered optioned shares in payment of the purchase price and withholding tax obligations. |
Common Stock
|
2,448 |
| 2025-11-21 | DEVILLIERS DAVID H JR |
Director, Sr. Advisor to Pres. & COO |
Sell↓
|
Common Stock
|
2,000 |
| 2025-11-13 | McNulty Matthew C. |
CFO |
Buy↑
|
Common Stock
|
1,000 |
| 2025-11-13 | BAKER JOHN D II |
Director |
Buy↑
|
Common Stock
(I)
|
854 |
| 2025-11-12 | BAKER JOHN D II |
Director |
Buy↑
|
Common Stock
(I)
|
7,175 |
| 2025-11-12 | McNulty Matthew C. |
CFO |
Buy↑
|
Common Stock
|
1,000 |
| 2025-11-10 | Baker John D. III |
Director, CEO |
Buy↑
|
Common Stock
(I)
|
4,166 |
| 2025-11-10 | BAKER JOHN D II |
Director |
Buy↑
|
Common Stock
(I)
|
334 |
| 2025-10-02 | Klopfenstein John D |
Controller & CAO |
Convert↑
|
Common Stock
|
760 |
| 2025-10-02 | Klopfenstein John D |
Controller & CAO |
Convert↓
|
Option to Buy
|
760 |
| 2025-05-12 | STEIN MARTIN E JR |
Director, Executive Chairman |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
3,650 |
| 2025-05-12 | Surface John S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
3,650 |
| 2025-05-12 | Wetherbee Margaret B. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
3,650 |
| 2025-05-12 | Thomas Nicole B. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
3,650 |
| 2025-05-12 | WALTON WILLIAM H III |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. This item has been amended to reflect the correct price. |
Common Stock
|
3,650 |
| 2025-05-12 | McAfee Matthew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person was awarded shares pursuant to the Company's director compensation arrangements. |
Common Stock
|
3,650 |
| 2025-03-14 | BAKER JOHN D II |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The original filing is being amended to reflect a correct transaction code. |
Common Stock
(I)
|
6,608 |
| 2025-03-05 | deVilliers David H III |
President & COO |
Buy↑
Filing footnotes — Common Stock (Direct)
The Reporting Person earned these shares of restricted stock pursuant to a performance share award granted January 1, 2023 under the Issuer's Equity Incentive Plan, based on the achievement of the performance-based vesting criteria for the two-year performance period ended December 31, 2024. 25% of the shares vested on March 5, 2025, and 25% will vest on December 31st of each of 2025, 2026, and 2027, subject to the Reporting Person's continued employment. |
Common Stock
|
1,356 |